BiDil® is indicated for the treatment of heart failure as an adjunct to standard therapy in self-identified black patients to improve survival, to prolong time to hospitalization for heart failure, and to improve patient-reported functional status Question: The results of BiDil® clinical trials were compelling…Expound on the results. Question : What role did FDA’s approval resulted in BiDil® being a great example of pharmacogenomics/pharmacogenetics in the U.S.?
BiDil® is indicated for the treatment of heart failure as an adjunct to standard therapy in self-identified black patients to improve survival, to prolong time to hospitalization for heart failure, and to improve patient-reported functional status
Question: The results of BiDil® clinical trials were compelling…Expound on the results.
Question : What role did FDA’s approval resulted in BiDil® being a great example of pharmacogenomics/pharmacogenetics in the U.S.?
Bidil is a heart failure medication that combines two drugs: hydralazine and isosorbide dinitrate.
It has been used in combination with other therapies to treat heart failure.
Vasodilators refer to both medicines.
They function by relaxing and enlarging blood vessels, making it easier for blood to flow to the heart.
Trending now
This is a popular solution!
Step by step
Solved in 3 steps
